You are here

Edoceo Devices

Summary

Your Investment Helps Fight Against Deadly Bacteria & Viruses

Edoceo Devices

The Rapid, Affordable & Accurate COVID-19 & Bacterial Testing Systems

Please read the Offering Circular before making an investment decision.

Offering Circular

  • #
  • #
  • #

Prototype images

Edoceo Devices is an emerging med-tech & biotech American company with an experienced management team, with Exclusive and Groundbreaking Technology that could Help in the fight against COVID-19 – as well as Future Viral and Bacterial Threats to our families and our normal way of life. The priority is finalizing the development and marketing of these technologies to produce two proprietary point-of-need detection biosensors - with the goal of providing essential rapid early warning to the presence of pathogens:

  • The Edoceo B-Detect™ - A portable virulent bacterial testing device
  • The Edoceo V-Detect™ - A portable virus biosensing device

Edoceo B-Detect and V-Detect have the potential to change the world of rapid, portable, affordable, and accurate testing for pathogens including virulent bacteria and the presence of a range of viruses.

These innovative detection platforms are being developed for the aquaculture, veterinary, health care, food processing and home monitoring markets, amongst others – Edoceo detection devices are based on the work led by our Chief Science Officer, the Multi-Award-Winning Dr. Kenneth Reardon - and in collaboration with scientists at Colorado State University for technology exclusively licensed to Edoceo after many years of research.

**IMPORTANT NEWS for INVESTORS**

As   a   potential   bonus   to   investors, having secured substantial access to supplies, we are commencing commercialization of a rapid, simple, saliva-based antigen kit for coronavirus testing – Edoceo A-Detect™ – giving the potential of early sales-generated revenues from this key market.

COVID-19 has taught us that we need to be better prepared so we can confront and conquer emerging and re-emerging infectious diseases and bacterial threats with calm confidence.

We at Edoceo Devices in the USA are excited to have these exclusive technologies ready for late-stage development and commercialization. We now need the help of the American people to bring these simple and effective first-defense detection devices into production – giving early investors a great opportunity to be part of an American solution to viral and bacterial threats. Imagine what an important difference we could make together for a better future for us and our families… Join us in this battle, by becoming stakeholders in Edoceo Devices!

Invest Now

Please read the Offering Circular before making an investment decision.

Offering Circular

edoceo Devices Investment opportunity

Public Offering Via Reg A+

  • Security Type: Common Shares
  • Share Price:$5.80 per share
  • Minimum Investment:$580
  • Maximum Offring Size:$20,000,001
Did You Know You Can Invest with Your IRA?
Our offering is approved by and available as a self-directed IRA investment with:

Trust-Company

Click here to learn more about how you can invest in EDOCEO DEVICES using your IRA. Or feel free to reach out to us and we would be happy to discuss the process with you.

Why Invest in Edoceo Devices?
  • Experienced Management Team (see here >>>) with a complimentary skillset to help guide a path to success
  • Proven technological solution a known problem (drug resistant bacteria & virus detection)
  • Exclusive technology license backed by prominent US University research and development
  • Relatively low investment threshold to become a shareholder
  • Immediately marketable product in a sought-after market (A-Detect™ for COVID-19 testing)
  • Relatively low capital requirement to finish future product development
  • Rapid product commercialization (anticipated within 12 months - B-Detect™)
  • Subsequent additional product commercialization (anticipated within 18 months – V-Detect™)
  • A considerable and growing market potential for each of the platform products

All of the above opinions are based on our objective analysis of the facts available to us at the time of writing; please read the Offering Circular before making an investment decision – or, for clarification, please contact us here

Invest Now Please read the Offering Circular before making an investment decision. Offering Circular

Watch this Video now for details...

Watch this video to discover why Edoceo Devices is a great opportunity for investors as it pioneers point-of-need testing devices for the COVID-19 disease and eventually viruses causing diseases like HIV, dengue fever, influenza, Zika, and Hepatitis C, plus domestic animal viruses, 160 bacterial pathogens, and superbugs!

Investing Helps Us:
Fight Against Deadly Bacteria and Viruses Quickly – Both Now AND in the Future

Invest Now Please read the Offering Circular before making an investment decision. Offering Circular

edoceo Devices Investment opportunity

Public Offering Via Reg A+

  • Security Type: Common Shares
  • Share Price:$5.80 per share
  • Minimum Investment:$580
  • Maximum Offring Size:$20,000,001
Did You Know You Can Invest with Your IRA?
Our offering is approved by and available as a self-directed IRA investment with:

Trust-Company

Click here to learn more about how you can invest in EDOCEO DEVICES using your IRA. Or feel free to reach out to us and we would be happy to discuss the process with you.

At Edoceo we make Sensors for Life. To create a safer world for us all.

Edoce Devices' Management Team

#
ROD REUM CPA, CGA
EXECUTIVE CHAIRMAN, CEO

Mr. Reum has 40 years of senior executive leadership of both public and private companies. He has played many key management roles in the financing of enterprises up to CAD $1.3 billion dollars for one project.

NICOLETTE KEITH, CPA, CGA
CHIEF FINANCIAL OFFICER

Ms. Keith has been a Chief Financial Officer for private and public companies listed on the TSX Venture and the Frankfurt exchanges. In addition, Ms. Keith held a senior accounting role for a public company listed on the New York Stock Exchange.

#
DR. KEN REARDON
CHIEF SCIENCE OFFICER

Dr. Reardon is Professor and Jud and Pat Harper Chair of Chemical and Biological Engineering and holds joint appointments in several other programs at Colorado State University, including Cell and Molecular Biology and Biomedical Engineering.

#
MIKE KAO, CPA, CGA
VP FINANCE

Mr. Kao is a partner of WDM Chartered Professional Accountants, a Vancouver-based firm with over 30 years experience. Mike is proficient with both.

Privacy Policy & Legal Disclaimers

Legal Disclaimer

Quara Devices Inc. (dba Edoceo Devices) Campaign

IMPORTANT NOTICE AND DISCLAIMER: All investments are subject to risk, which must be considered on an individual basis before making any investment decision. This is a paid advertisement to bring market awareness to Quara Devices Inc. (dba Edoceo Devices), its products and services, and a related private equity investment opportunity under Regulation A+ of the JOBS Act. This advertisement is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security. Neither this advertisement or Edoceo purport to provide a complete analysis of any company or its financial position. This advertisement is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company’s SEC and/or other government filings. Investing in securities, particularly illiquid securities, is speculative and carries a high degree of risk. Past performance does not guarantee future results. This advertisement contains forward-looking statements, including statements regarding Edoceo’s expected continual growth. Quara Devices Inc. (dba Edoceo Devices) notes that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect the company’s actual results of operations. Factors that could cause actual results to differ include the size and growth of the market for the company’s products and/or services, the company’s ability to fund its capital requirements in the near term and long term, pricing pressures, etc. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of this advertisement is made or implied. Devices Inc. (dba Edoceo Devices) is not affiliated, connected, or associated with, and are not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made to any rights in any third-party trademarks.

Offering Circular

AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. IT DOES NOT MEAN THAT THE SEC HAS APPROVED, PASSED UPON THE MERITS OR PASSED UPON THE ACCURACY OR COMPLETENESS OF THE INFORMATION IN THE OFFERING STATEMENT. YOU MAY OBTAIN A COPY OF THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT FROM:

YOU SHOULD READ THE OFFERING CIRCULAR BEFORE MAKING ANY INVESTMENT HERE .

THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.

Comments

Post comment

Offering Circular

Please read the Offering Circular here: Get Offering Circular

AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. IT DOES NOT MEAN THAT THE SEC HAS APPROVED, PASSED UPON THE MERITS OR PASSED UPON THE ACCURACY OR COMPLETENESS OF THE INFORMATION IN THE OFFERING STATEMENT. YOU MAY OBTAIN A COPY OF THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT FROM:

https://www.manhattanstreetcapital.com/offering-circular/24851

YOU SHOULD READ THE OFFERING CIRCULAR BEFORE MAKING ANY INVESTMENT.

THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.